COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis
Research article
[키워드] 1:1
Acute kidney injury
acute respiratory distress
adjust
African American
AKI
Analysis
ARDS
association
Black race
Cancer patients
cohort analysis
confounders
Control
controls
COVID-19
database
dermatomyositis
determine
develop
Disease activity
drug
Gender
General population
glucocorticoid
heterogeneous nature
High dose
higher odd
hospitalisation
ICU admission
identify
ILD
Immunosuppressant
immunosuppressive
individual
Infection
Interstitial lung disease
lower risk
male
mechanical ventilation
Mortality
neoplasm
Neoplasms
outcome
outcomes
Patient
patients with COVID-19
Precaution
receiving
renal replacement therapy
required
retrieved
retrospective data
rheumatic disease
risk
RRT
score
Sepsis
severe COVID-19
Severe COVID-19 Infection
severity of COVID-19
stroke
Subgroup analysis
syndrome
therapy
Treatment
Venous Thromboembolism
VTE
was used
with COVID-19
[DOI] 10.1016/j.semarthrit.2022.152034 [Article Type] Research article
[DOI] 10.1016/j.semarthrit.2022.152034 [Article Type] Research article